Background: Follicle-stimulating hormone receptor () and luteinizing hormone/choriogonadotropin receptor () are integral to ovarian function, facilitating follicle development and maturation through their respective hormonal interactions. The influence of receptor polymorphisms on the outcomes of freeze-all cycles remains unclear.
Objective: This study investigates the impact of and polymorphisms on clinical outcomes in freeze-all cycles.